by IR Team | Dec 14, 2020 | Press Release
SAN DIEGO – December 14, 2020 – AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological and COVID-19 research, announced today that the Company’s CEO John W. Huemoeller...
by IR Team | Dec 4, 2020 | News
A new enzyme-linked immunosorbent assay (ELISA)-based COVID-19 diagnostic test detects and ranks SARS-CoV-2 neutralizing antibodies by their potency in a simple and relatively short test time. The test developed internally by AXIM Biotechnologies, Inc. (San Diego, CA,...
by IR Team | Dec 4, 2020 | News
Intrivo Diagnostics announced that it has entered into a national distribution agreement with Concordance Healthcare Solutions and NDC to start the distribution and commercialisation of New Jersey-based Access Bio’s CareStart™ line of coronavirus testing products...
by IR Team | Dec 3, 2020 | News
3M, of St Paul, Minn., said it is planning to initiate restructuring actions that will impact all business groups, functions and geographies. The restructuring is expected to affect about 2,900 positions globally. Santa Clara, Calif.-based Agilent Technologies...
by IR Team | Dec 3, 2020 | Press Release
SAN DIEGO, December 3, 2020 — AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or the “Company”), an international healthcare solutions company targeting oncological and COVID-19 research, announced today the development and patent filing for...